BG
Bellevue Group Portfolio holdings
AUM
$4.54B
1-Year Return
22.5%
This Quarter Return
+13.81%
1 Year Return
+22.5%
3 Year Return
+98.22%
5 Year Return
+159.37%
10 Year Return
–
AUM
$7.53B
AUM Growth
+$567M
(+8.1%)
Cap. Flow
-$9.29M
Cap. Flow
% of AUM
-0.12%
Top 10 Holdings %
Top 10 Hldgs %
36.11%
Holding
184
New
8
Increased
71
Reduced
51
Closed
13
Top Buys
| 1 |
Incyte
INCY
|
$17.1M |
| 2 |
Intuitive Surgical
ISRG
|
$15.7M |
| 3 |
DexCom
DXCM
|
$14.5M |
| 4 |
Centene
CNC
|
$13.5M |
| 5 |
Abbott
ABT
|
$12.6M |
Top Sells
| 1 |
ABMD
Abiomed Inc
ABMD
|
$40.9M |
| 2 |
UnitedHealth
UNH
|
$38.4M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
$32.9M |
| 4 |
Elevance Health
ELV
|
$27.2M |
| 5 |
Molina Healthcare
MOH
|
$18M |
Sector Composition
| 1 | Healthcare | 99.55% |
| 2 | Industrials | 0.38% |
| 3 | Energy | 0.03% |
| 4 | Communication Services | 0.01% |
| 5 | Consumer Discretionary | 0% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
126
Kosmos Energy
KOS
$784M
| $2.02M | 0.03% |
318,300
| – | – |
|
127
Cencora
COR
$56.7B
| $1.69M | 0.02% |
10,210
-1,700
| -14% | -$282K |
|
128
Alkermes
ALKS
$4.94B
| $1.58M | 0.02% |
+35,500
| New | +$1.58M |
|
129
Krystal Biotech
KRYS
$4.35B
| $1.45M | 0.02% |
18,300
| – | – |
|
|
KRTX
130
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $1.43M | 0.02% |
+7,300
| New | +$1.43M |
|
|
HZNP
131
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
| $1.41M | 0.02% |
12,411
-289,439
| -96% | -$32.9M |
|
132
Arcus Biosciences
RCUS
$1.3B
| $1.36M | 0.02% |
65,864
-17,636
| -21% | -$365K |
|
133
Viridian Therapeutics
VRDN
$1.53B
| $1.35M | 0.02% |
46,100
| – | – |
|
134
Agilent Technologies
A
$36.5B
| $1.19M | 0.02% |
7,978
-649
| -8% | -$97.1K |
|
135
McKesson
MCK
$85.5B
| $1.1M | 0.01% |
2,920
-18
| -0.6% | -$6.75K |
|
|
CELL
136
DELISTED
PhenomeX Inc. Common Stock
CELL
| $1.03M | 0.01% |
385,014
| – | – |
|
|
ISEE
137
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
| $895K | 0.01% |
+41,800
| New | +$895K |
|
138
Arrowhead Research
ARWR
$4.02B
| $864K | 0.01% |
+21,300
| New | +$864K |
|
139
Denali Therapeutics
DNLI
$2.26B
| $862K | 0.01% |
31,000
| – | – |
|
140
Cardinal Health
CAH
$35.7B
| $815K | 0.01% |
10,600
+9,682
| +1,055% | +$744K |
|
141
Seer Inc
SEER
$118M
| $790K | 0.01% |
136,133
| – | – |
|
142
Labcorp
LH
$23.2B
| $784K | 0.01% |
3,876
-664
| -15% | -$134K |
|
143
Merck
MRK
$212B
| $749K | 0.01% |
6,751
+1,907
| +39% | +$212K |
|
|
INBX
144
DELISTED
Inhibrx, Inc. Common Stock
INBX
| $732K | 0.01% |
29,700
-13,800
| -32% | -$340K |
|
145
Rocket Pharmaceuticals
RCKT
$354M
| $716K | 0.01% |
+36,600
| New | +$716K |
|
146
Merus
MRUS
$5.1B
| $707K | 0.01% |
45,700
+20,300
| +80% | +$314K |
|
147
SPDR S&P 500 ETF Trust
SPY
$660B
| $688K | 0.01% |
1,800
| – | – |
|
148
Xencor
XNCR
$610M
| $661K | 0.01% |
25,400
| – | – |
|
149
NovoCure
NVCR
$1.37B
| $660K | 0.01% |
+9,000
| New | +$660K |
|
150
Alphabet (Google) Class C
GOOG
$2.84T
| $532K | 0.01% |
6,000
| – | – |
|